IOLCP

The stock has been placed in Additional Surveillance Measure (ASM) list LTASM - I (13).

IOL Chemicals And Pharmaceuticals Ltd.

NSE: IOLCP

BSE: 524164

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

205.71-3.7 (-1.76%)

5 Oct, 3:30 PM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

51.6 / 100

Value Score

41.7 / 100

Price Momentum Score

98.4 / 100

QVM Score

78.1 / 100

Key Metrics

Market Cap

6146.18

P/E (TTM)

36.56

P/B

3.42

P/S (TTM)

2.44

EV/EBITDA

19.57

CAPE (5Y)

45.38

ROE (TTM)

7.90

ROCE (TTM)

10.10

ROA (TTM)

5.54

Avg 3Y ROE

7.55

Earnings 3Y CAGR

3.76

Sales 3Y CAGR

4.44

Sales 5Y CAGR

4.50

Debt/Equity

0.08

Consensus TP

223.00

Strong Buy %

Promoter Holding

62.28

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of IOL Chemicals And Pharmaceuticals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 98.4 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

98.4 / 100

Analysts have been raising forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has increased by 21.24% in the last 3 months, indicating earnings momentum

What is Earnings upgrade (3M)?

Moderate revenue growth and above median growth of industry

The company delivered moderate revenue growth of 18.56% for 12-month ended 30 Jun 2026 and the growth was 7.88 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 10.68

Value 18.56

-99.6111701.8

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 59.74% for 12-month ended 30 Jun 2026 and the growth was 52.29 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.08 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.01 in the last 1 year

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 7 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 36.56 indicates that the stock is expensive on a standalone basis and is at a 13.43% premium to industry median P/E

What is P/E Ratio?

Median: 32.23

Value 36.56

-0.81734.31

Low dividend yield

The company has a low dividend yield of 0.48%

What is Dividend yield?

Neutral

Low ROE but improving trend

The company reported low ROE of 7.9% for 12-month ended 30 Jun 2026 but ROE improved by 176 bps from 1 year ago

What is ROE (FY)?

Low operating margin but improving trend

The company reported low operating margin of 8.14% for 12-month ended 30 Jun 2026 but operating margin improved by 163 bps from 1 year ago

What is Operating profit margin?

Company's earnings are of moderate quality

Earnings quality score of 68.7 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

68.7 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for IOL Chemicals And Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

IOL Chemicals And Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of IOL Chemicals And Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	41.89	43.69	43.69	43.69	43.69	43.69	43.69	43.69	43.69	43.69	43.69	43.69	48.19	48.19	48.19	48.19	48.19	48.19	48.19	52.62	52.62	52.62	52.62	52.62	57.48	62.28
Indian Promoter	41.89	43.69	43.69	43.69	43.69	43.69	43.69	43.69	43.69	43.69	43.69	43.69	48.19	48.19	48.19	48.19	48.19	48.19	48.19	52.62	52.62	52.62	52.62	52.62	57.48	62.28
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	2.87	6.72	6.42	7.83	6.02	5.09	3.12	3.54	3.18	2.54	2.46	2.53	2.66	3.79	2.69	2.54	1.70	1.48	1.70	1.56	1.54	2.61	2.29	2.10	1.74	5.30
Mutual Funds / UTI	0.02	0.02	0.02	0.03	0.04	0.04	0.36	0.50	0.02	0.02	0.02	0.02	0.02	0.02	0.05	0.06	0.08	0.09	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02
FI/Bank/Insurance	0.24	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	2.61	6.47	6.40	7.77	5.96	5.05	2.76	3.03	3.14	2.50	2.41	2.37	2.43	3.54	2.33	2.18	1.40	1.39	1.63	1.49	1.47	2.59	2.25	2.08	1.72	4.87
Other Institutions	0.00	0.00	0.00	0.02	0.02	0.00	0.00	0.00	0.02	0.03	0.03	0.14	0.21	0.23	0.30	0.30	0.21	0.00	0.05	0.05	0.05	0.00	0.02	0.00	0.00	0.41
Non-Institution	55.24	49.59	49.89	48.48	50.29	51.21	53.18	52.77	53.13	53.77	53.83	53.78	49.15	48.02	49.13	49.27	50.11	50.34	50.11	45.82	45.84	44.77	45.09	45.28	40.78	32.42
Bodies Corporate	25.61	21.59	19.76	19.70	19.35	19.61	19.77	19.56	19.54	19.71	19.71	19.77	15.60	15.73	15.75	15.37	15.74	15.35	15.33	10.95	10.87	11.18	11.58	11.26	6.38	2.44
Others (incl. Retail) No. of shareholders	29.63 36,450	28.00 43,867	30.13 81,521	28.78 85,677	30.94 1,08,658	31.60 1,27,402	33.41 1,41,476	33.21 1,44,508	33.59 1,45,929	34.06 1,48,404	34.12 1,45,191	34.01 1,42,821	33.55 1,39,675	32.29 1,25,513	33.38 1,34,883	33.90 1,33,764	34.37 1,29,569	34.99 1,28,279	34.78 1,25,554	34.87 1,26,261	34.97 1,29,569	33.59 1,24,591	33.51 1,35,655	34.02 1,33,062	34.40 1,31,098	29.98 1,18,861

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

IOL Chemicals And Pharmaceuticals Ltd. is not part of any tracked index.

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in IOL Chemicals And Pharmaceuticals Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
NCVI Enterprises Limited Promoter Group	March-2026	Market Purchase (Acquisition) 20th Mar 2026	16.44 %	₹ 74.56	4.04 lac	₹ 3.01 cr
Mayadevi Polycot Limited Promoter Group	March-2026	Market Purchase (Acquisition) 19th Mar 2026	21.76 %	₹ 73.81	54.20 k	₹ 40.00 lac
NCVI Enterprises Limited Promoter Group	March-2026	Market Purchase (Acquisition) 19th Mar 2026	16.20 %	₹ 73.44	7.00 lac	₹ 5.14 cr
Mayadevi Polycot Limited Promoter Group	March-2026	Market Purchase (Acquisition) 18th Mar 2026	21.54 %	₹ 68.36	6.54 lac	₹ 4.47 cr
NCVI Enterprises Limited Promoter Group	March-2026	Market Purchase (Acquisition) 18th Mar 2026	15.96 %	₹ 68.89	7.00 lac	₹ 4.82 cr
Damandeep Singh Designated Person	August-2021	Market Sale (Disposal) 24th Aug 2021	0.00 %	₹ 567.14	2.48 k	₹ 14.04 lac
Damandeep Singh Designated Person	August-2021	Market Sale (Disposal) 24th Aug 2021	0.01 %	₹ 605.00	3.52 k	₹ 21.33 lac
Damandeep Singh Designated Person	April-2021	Market Sale (Disposal) 7th Apr 2021	0.01 %	₹ 582.35	1.70 k	₹ 9.90 lac
Damandeep Singh Designated Person	March-2021	Market Sale (Disposal) 17th Mar 2021	0.02 %	₹ 649.87	3.85 k	₹ 25.02 lac

Corporate Actions

History of IOL Chemicals And Pharmaceuticals Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 1/share
Record date: 17th Feb 2026Ex-date: 17th Feb 2026
Announced on: 11th Feb 2026
Stock Split1 : 5
Ex-date: 11th Mar 2025Announced on: 27th Dec 2024
Nominal value change from INR 10 to INR 2.
Dividend₹ 4/share
Record date: 18th Feb 2025Ex-date: 18th Feb 2025
Announced on: 12th Feb 2025
Dividend₹ 5/share
Record date: 16th Feb 2024Ex-date: 16th Feb 2024
Announced on: 6th Feb 2024
Dividend₹ 4/share
Record date: 17th Feb 2023Ex-date: 17th Feb 2023
Announced on: 1st Feb 2023

Company Profile

Overview of IOL Chemicals And Pharmaceuticals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Ac...

Key personnel

Mr. Pardeep Kumar Khanna

Chief Financial Officer

Mr. Abhay Raj Singh

Senior Vice President, Company Secretary

Sri. Rajender Mohan MallaD

Independent Chairman of the Board

Mr. Varinder GuptaD

Managing Director, Executive Director

Mr. Vikas GuptaD

Joint Managing Director, Executive Director

Mr. Abhiraj GuptaD

Executive Director

Mr. Kushal Kumar RanaD

Director - Works, Executive Director

Ms. Rajni JhaD

Independent Director

View all

Incorporated on

29 Sep 1986

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

3,095

IPO date

05 Nov 2010

Free Float

11,07,27,510

Website

https://www.iolcp.com/

Phone no.

+911612225531

Address

85, Industrial Area, `A,, LUDHIANA, 141003, India

Frequently Asked Questions

What is the current share price of IOL Chemicals And Pharmaceuticals Ltd.?

The current share price of IOL Chemicals And Pharmaceuticals Ltd. is ₹ 205.71 as of 5 Oct 2026.

What is the market capitalisation of IOL Chemicals And Pharmaceuticals Ltd.?

The market capitalisation of IOL Chemicals And Pharmaceuticals Ltd. stands at ₹ 6,146.18 Cr.

What is the PE ratio of IOL Chemicals And Pharmaceuticals Ltd.?

The Price-to-Earnings (PE) ratio of IOL Chemicals And Pharmaceuticals Ltd. is 36.56 as of the latest trailing twelve months data.

What is the ROE and ROCE of IOL Chemicals And Pharmaceuticals Ltd.?

IOL Chemicals And Pharmaceuticals Ltd. has a Return on Equity (ROE) of 7.90% and a Return on Capital Employed (ROCE) of 10.10% as per the latest financial reports.

What is the 52-week high and low of IOL Chemicals And Pharmaceuticals Ltd.?

The 52-week high of IOL Chemicals And Pharmaceuticals Ltd. is - and the 52-week low is -.

What is the dividend yield of IOL Chemicals And Pharmaceuticals Ltd.?

The dividend yield of IOL Chemicals And Pharmaceuticals Ltd. is 0.48% based on the current market price.

What is the FII and DII holding in IOL Chemicals And Pharmaceuticals Ltd.?

Foreign Institutional Investors (FII) hold 4.87%, Domestic Institutional Investors (DII) hold 0.02% and retail/public investors hold 29.98% of IOL Chemicals And Pharmaceuticals Ltd. shares.

What sector does IOL Chemicals And Pharmaceuticals Ltd. belong to?

IOL Chemicals And Pharmaceuticals Ltd. operates in the Healthcare sector.

What is the beta of IOL Chemicals And Pharmaceuticals Ltd.?

The beta of IOL Chemicals And Pharmaceuticals Ltd. is 1.21, indicating its price volatility relative to the broader market. Over the past 1 year, IOL Chemicals And Pharmaceuticals Ltd. has delivered an absolute return of 82.87%.

What is the RSI of IOL Chemicals And Pharmaceuticals Ltd.?

The 14-day Relative Strength Index (RSI) of IOL Chemicals And Pharmaceuticals Ltd. is 60.61, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

IOL Chemicals And Pharmaceuticals Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

IOL Chemicals And Pharmaceuticals Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Company Profile

Stock Analysis

Corporate Actions

Holdings and Presence